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A.10 ABSTRACTS 
included: FEVl ~35% (46.4% vs. 22.4%; P=O.O47), use of home oxygen (60.7% vs. 156%; P<O.OOOl), frequency of 
exacerbation (3.822.0 vs. 1.6r0.91; P<O.OOl), history of previous pneumonia (64.3% vs. 35.1%; P<O.O07), history of sinusitis 
(28.6% vs. 88%; P<O.O09) and use of maintenance steroids (32.1% vs. 15.2%; P=O.O52). Using stepwise logistic regression 
analysis to identify the top independent variables, the use of home oxygen (P=O.O002) and frequency of exacerbation 
(P<O.OOOl) correctly classified failures in 83.3% of the patients. Surprisingly, age, the choice of an antibiotic and the presence 
of any one or more comorbidity did not affect the treatment outcome. 
Conclusion. The results of our study suggest that patient host factors and not antibiotic choice may determine treatment 
outcome. Prospective studies in appropriately stratified patients are needed to validate these findings. 
Study partly supported by a research grant from Bayer Pharmaceuticals, Inc. Data also presented previously at American 
College of Chest Physicians in Toronto, Canada, November 10, 1998. 
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Background: Lower respiratory tract infections are often the cause of acute excarbations, and the treatment of infection is an 
important part of therapy of COPD. 
Objective: To compare the effects of erythromycin with other routinly prescribed antibiotics in patients with acute purulent 
exacerbations of COPD. 
Methods: Eighty-two patients with acute purulent exacerbation of COPD were randomized to receive either a course of orally 
administered antibiotic therapy with erythromycin 500 mg every 6 h for 10 days (n=42), or a standard course of oral 
antibiotics (doxycycline100 mg every 12 h for 10 days or cefaclor 500 mg every 8 h for 10 days) (n=40). The two groups of 
patients were comparable in their clinical and spirometric profiles. 
Results: In the erythromycin group spirometric values, PEFR scores, symptom scores and physician global evaluations were 
statistically significantly better (P<O.OOl) compared with control group. In both groups treatment was well tolerated, with 
similar incidence of side effects. 
Conclusion: Erythromycin is effective and appropriate antibiotic for the treatment of acute bacterial exacerbations in patients 
with COPD. 
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Four different bacterial sampling chambers containing Mueller Hinton culture medium in Petri dishes have been compared 
for demonstrating the best results using the same portable aerodispersed particles sampler (PARTRAP FA 52) with aspiration 
flow of 10 liters per minute, equivalent to Current Volume of adult respiratory flow at rest. Twenty environmental 
aerobiological samplings were performed per 30 minutes with each different chamber in the same environment (Pneumonology 
Service). The cylindrical chambers made in aluminium differed essentially in the varying diameter of the punctured surface 
which allowed air passage and a diverse impact of the air column on the surface of the 7.5 cm diameter Petri dishes. Differing 
diaphragm diameter applied at the opening of the sampler chamber causes a different spatial distribution of bacterial growth. 
Optimal bacterial growth expressed in Colony Forming Units (CFU) and in regular distribution on the Petri dish surface was 
obtained with a type of sampling chamber with a central punctured diaphragm of 5 cm diameter, in this case all the bacterial 
colonies were well identified as a ‘stars in the sky’, in the other chambers the growth was present respectively in the central 
part of the Petri dish, or in periphery with high Colony Forming Units (CFU) concentration and sometimes it was impossible 
to determine it correctly. A portable, light (approximately 500 g.), low cost aerodispersed particle sampler apparatus may be 
useful in sampling bacterial and/or mould particles directly on Petri dishes for great practical importance in the determination 
of hygienic conditions of the sanitary environment. 
